One term addressed is the so-called “TGF-β paradox”, which refers to the dual impact of TGF-β on cancer progression, as TGF-β can act as a potent tumor suppressor in early-stage tumors by inducing robust antiproliferative responses, cellular differentiation, and apoptosis [63]. The gene discussed is TGFB1; the disease is neoplasm.